Pregabalin Stabilize Cardiovascular Response to Intubation

• Status: Completed
• Trial end date: 2017-06-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate whether Pregabalin is safe and effective in stabilizing cardiovascular response to laryngoscopy and tracheal intubation of patients under general anesthesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Zhongshan Hospital
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists(ASA) grade I and II scheduled for elective surgery

Exclusion Criteria:

• patient refusal.

• patients with serious chronic kidney, liver, lungs, or cardiovascular diseases.

• allergy to any of the study medications.

• patients taking sedation or antihypertensive medications.

• suspected difficult intubation or intubation time more than 22s.

• pregnant or breastfeeding women.

• BMI>30.